Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Allergen or component thereof
Patent
1981-03-16
1983-05-24
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Allergen or component thereof
A61K 3138
Patent
active
043850642
ABSTRACT:
A method for the treatment of the acute pain crises of sickle cell anemia has been found which comprises the administration of the citrate or the oxalate salt of the 2-hexahydro-1H-azepin-1-yl)ethyl ester of .alpha.-cyclohexyl-3-thiopheneacetic acid.
REFERENCES:
patent: 4005095 (1977-01-01), Robba et al.
The Merck Index, Ninth Ed., (1976), Merck & Co., Inc., Rahway, N.J., p. 253.
Science, vol. 211, 30 Jan. 1981, pp. 468-470.
"Medical Diagnosis Treatment 1977", pp. 289-291.
Arch Intern Med., pp. 698-705.
"Cetiedil: Its Potential Usefulness in Sickle Cell Disease", Blood, pp. 265-270.
Laboratories Innothera, S.A.
Waddell Frederick E.
LandOfFree
Method for treating sickle cell anemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating sickle cell anemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating sickle cell anemia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2146112